on 12 Mar 2024
Last Applicant/ Owned by
Tokyo 113-8485
JP
Serial Number
79347683 filed on 18th May 2022
Registration Number
7324426 registered on 12th Mar 2024
Correspondent Address
Karen Lim
Filing Basis
1. filing basis filed as 66 a
Disclaimer
"THERAPEUTICS"
Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs "THERAPEUTICS" Blood testing and analysis; provision of information on blood tests; providing medical information and consultation; blood bank services; rental of blood filtration units; medical services relating to the removal, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bo Read More
Blood testing and analysis; provision of information on blood tests; providing medical information and consultation; blood bank services; rental of blood filtration units; medical services relating to the removal, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow
Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs
Treatment and processing of human cells for others; treatment and processing of cells for medical use; cryogenic preservation; custom manufacture of pharmaceutical preparations for others; treatment and processing of blood and blood products
Pharmaceutical preparations for the prevention and treatment of cancers; pharmaceutical preparations for the prevention and treatment of hematological malignancies; pharmaceutical preparations for the prevention and treatment of non-hematological malignancies; pharmaceutical preparations for the prevention and treatment of genetic disorders; pharmaceutical preparations for use as gene therapy agent; pharmaceutical preparations for use as regenerative medicine agent; cells for medical use; blood products for the prevention and treatment of cancers; blood products for the prevention and treatment of hematological malignancies; blood products for the prevention and treatment of non-hematological malignancies; blood products for the prevention and treatment of genetic disorders; blood products for use as gene therapy agent; blood products for use as regenerative medicine agent; blood for medical purposes; hemotropic agents for stimulation of cell function, gene therapy, cell therapy, and for use as blood substitutes; cellular function activating agents for medical purposes; reagents for medical use; cell preparations for the treatment of diseases and disorders; clinical diagnostic reagents; stem cells for medical purposes
Chemical reagents for non-medical purposes, chemicals for use in the manufacture of pharmaceuticals; reagents for scientific and research use
No 79347683
No Service Mark
No CLDT 2309434
No
No
No
No
Yes
Yes
No
No
26.01.13 -
Two circles
26.01.16 -
Circles touching or intersecting
26.01.21 -
Circles that are totally or partially shaded
The mark consists of the stylized word "CELAID" with the letters "CELA" and "D" in black and the letter "I" in pink. The stylized word "THERAPEUTICS" appears below in black. To the left of the wording, the design of two irregular circles appears, with the lower circle in pink and the upper circle in blue. The overlapping area of the circles appears in purple.
Status Date | Action Taken |
---|---|
12th Mar 2024 | REGISTERED-PRINCIPAL REGISTER |
12th Mar 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
13th Feb 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
24th Jan 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
24th Jan 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
26th Dec 2023 | PUBLISHED FOR OPPOSITION |
26th Dec 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
26th Dec 2023 | NOTIFICATION PROCESSED BY IB |
06th Dec 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
06th Dec 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |